And now for something completely indifferent
By Green Shield Canada
To listen to an audio podcast, mouse over the title and click Play. Open iTunes to download and subscribe to podcasts.
Welcome to “And now for something completely indifferent”, a Canadian health benefits industry podcast, brought to you by your friends at Green Shield Canada (GSC).
||CleanEpisode 13: On the air with Stephen Frank||In episode 13, hosts Sarah Murphy and David Willows explain why this is their first ever “Emergency Podcast”, namely the return of CLHIA’s President and CEO Stephen Frank to talk about one of the most talked about industry initiatives, CLHIA's Guideline, a much-debated move to compel disclosure of advisor compensation (1:16). Stephen gives the background to the issue and walks listeners through the why, the how, and the when around G19 (3:20). Other meaty topics include an update on the consultations on National Pharmacare (14:09), the industry’s focus on better managing fraud (21:15), and a look ahead to issues that could emerge in 2019 (25:13). Last, David and Stephen get into an unpleasant spat about the futures of their Toronto Maple Leafs and Ottawa Senators (29:25).||12/2/2018||Free||View in iTunes|
||CleanEpisode 12: Re-imagining Health Benefits||In episode 12, hosts Sarah and David debate the proper dressing of the bed that resides in the podcast studio/wellness room (1:14). The podcast starts in earnest with the introduction of guests Erin Crump (GSC’s Leader of Strategic Innovation) and Ned Pojskic (GSC’s Leader of Pharmacy and Health Provider Strategy) and an initial discussion on why private health benefits plans have been so static for so long, and why measuring value (health outcomes) for spend has not been made a priority in Canada (3:54). Ned then discusses the scrutiny placed on new drug products versus the lack of research and evidence available for other health benefits (9:30). Erin presents the background to, and construct of, GSC’s new SMARTspend™ plan design, poised to be released early October (15:45). Last, David wonders what the response will be from the plan advisors and sponsors to GSC’s efforts to evolve plan design (25:05).||9/10/2018||Free||View in iTunes|
||CleanEpisode 11: "Customer Experience" and the insurance industry||In episode 11, host Sarah listens to David defend his attempt at humour contained later in the podcast (1:17). While she remains unconvinced, guest Steve Mast is welcomed and introduces his company Delvinia (and his role as President and Chief Innovation Officer) to listeners (4:05). Steve defines the concept of “customer experience” and how employee engagement contributes to it (9:17). David challenges Steve to rate the Canadian insurance industry on customer experience and wonders whether the complex regulatory environment thwarts a truly great or “innovative” one (12:35). Steve provides advice to insurers (based on consumer survey data) on improving their experiences and addresses the different expectations of generations of customers, particularly Millennials and Generation Z (18:18). Last, Steve looks at a ten-year horizon and provides three final thoughts on customer experience for the industry (24:36).||8/16/2018||Free||View in iTunes|
||CleanEpisode 10: Value-based Benefits||In episode 10, hosts Sarah and David celebrate the recording of the tenth podcast and discuss the topic of value-based benefits with guests Ned Pojskic, GSC’s Leader of Pharmacy and Health Provider Relations, and William Chung, Shoppers Drug Mart’s Senior Vice President of Payor Partnerships and Pricing (1:16). William explains his professional journey and his role as a SVP at Shoppers Drug Mart (3:09). GSC colleague Ned explains the ideas behind value-based healthcare and benefits (5:22) and William comments on Canadian Pharmacy’s readiness for a value-based world (8:04). Ned then explicitly explains GSC’s Value-based Pharmacy initiative (13:55) and William responds with Canadian Pharmacy’s reaction to it (16:50). Last, Ned reacts to Canadian Pharmacy concerns and suggests where common ground can be found (27:50).||6/17/2018||Free||View in iTunes|
||CleanEpisode 9: Chronic Pain||In Episode 9, hosts Sarah and David welcome friend and colleague Peter Gove back into the studio along with Founder and CEO of ManagingLife, Tahir Janmohamed, to discuss the complex topic of chronic pain. After detailing an unhealthy but satisfying weekend in Detroit (1:15), Sarah and David introduce Peter and Tahir and have them define chronic pain and typical patient profiles (4:16). Then our guests speak to the traditional treatment and suggest the ways it should evolve with the better understanding of the condition we are now developing. (8:50). David asks about the connection with chronic pain and opioids (15:07) and Tahir explains the App his company has built to support patients (18:04).||5/6/2018||Free||View in iTunes|
||CleanEpisode 8: Putting pharmacogenomics to the test...||In episode 8, hosts Sarah and David engage two guests, GSC’s Leader of Pharmacy and Health Provider Relations, Ned Pojskic, and former Canadian Pharmacist of the Year, and keen researcher, John Papastergiou. To start, Ned gets to refute GSC colleague Peter Gove’s assertion that his Ph.D. in Pharmaceutical Policy is anything but legitimate. (1:10) Things turn serious quickly as Ned defines pharmacogenomics and John tells us about his past research in the field. (3:20) Ned and John then take us through the details of the joint research project that is kicking off this Spring, examining mental health patients who are given a pharmacogenomics test. (9:30) David asks them to describe the best case scenario for the research results and where barriers to using the science may lie. (20:45) Last, David asks John about the role physicians can play, positively and negatively, as gatekeepers to pharmacogenomics. (24:50)||4/9/2018||Free||View in iTunes|
||CleanEpisode 7 - Biosimilars... to switch or not to switch...||In episode 7, hosts Sarah Murphy and David Willows discuss David’s first attempt to record an interview without Sarah in the studio (1:13). David then introduces podcast guests Ned Pojskic, GSC’s Leader, Pharmacy and Health Provider Relations, and Cheryl Koehn, the Founder and President of patient organization Arthritis Consumer Experts (4:05). David asks Ned to describe Canada’s progress with biosimilar adoption (spoiler alert – it is poor) and what public/private payors are (not) doing to support their introduction into the Canadian health care environment (6:30). Next, Cheryl explains the perspective of a patient organization that supports the adoption of biosimilars (13:55), and discusses the challenges of moving the physician community to new approaches in an environment where originator biologics manufacturers have systemic advantages in reaching physicians/patients (21:30). Ned and Cheryl address the “fear-mongering” that still happens on this topic (25:18), and David ends the discussion by asking whether they are concerned or optimistic about the future of biosimilar adoption in Canada (29:54).||3/28/2018||Free||View in iTunes|
||CleanEpisode 6: Financial health||In episode 6, hosts Sarah Murphy and David Willows invite GSC’s health innovation leader Peter Gove back to the studio to discuss financial health and its impact on broader mental health. But first Peter discusses his pride at being a three time podcast guest and the rivalry he feels with fellow team members to maintain his lead in that category. Peter and David then dive into a discussion of the financial health of group plan members in Canada, its impact on mental health, and strategies to help them do better (4:34). David then asks Peter to revisit earlier podcast discussions on mental health and comment on recent headlines that suggested half of Canadians have experienced a “mental health issue” (14:12). Last, Sarah and David introduce the first edition of the Ask the Pharmacist podcast, this one addressing the quality of care in Canadian pharmacies and what the average patient can do to maximize the experience (22:43).||3/11/2018||Free||View in iTunes|
||CleanEpisode 5: An interview with Stephen Frank, president of the CLHIA||In episode 5, hosts Sarah Murphy and David Willows welcome to the studio Stephen Frank, President and CEO of the Canadian Life and Health Association (CLHIA). Stephen tells listeners about the CLHIA and how his background as an economist and in the financial industry landed him his gig (@ 5:35). Stephen then talks about the industry’s most prominent challenges in 2017, namely Canadians’ access to prescription drugs and their rising costs (@ 9:35). David challenges Stephen to answer critics of the industry drug pool (@ 12:15), and to describe a path where the cost of drugs can be better managed (@ 15:35). Next, Stephen looks into his crystal ball and predicts the big issues that will confront the industry in 2018 (@22:25). Last, David asks Stephen to identify issues on which the insurance industry is justifiably critiqued and ones for which he thinks it is unjustly criticized (@ 28:51).||2/18/2018||Free||View in iTunes|
||CleanEpisode 4: Artificial Intelligence, Machine Learning and the Health Benefits Industry||In the fourth episode of GSC’s podcast, hosts Sarah Murphy and David Willows explore the world of Artificial Intelligence and Machine Learning and its potential relevance in the health benefits space. After guests from MEMOTEXT, Amos Adler and Bill Simpson, are introduced (@ 2:35), Amos and Bill explain what their cool start-up is doing to help companies in our industry (@ 6:34) and do their best to define Artificial Intelligence and Machine Learning for lay people (@ 10:19). Finally, the Memotext guys explain what Artificial Intelligence/Machine Learning already exists in the Canadian health care landscape (@ 15:07) and make their bold predictions for its future use (@ 18:38).||1/21/2018||Free||View in iTunes|